MOUNTAIN VIEW, Calif., April 29, 2015 /PRNewswire/ -- The trend of laboratories moving from manual methods to automated workflows is advancing momentum in the uptake of liquid handling instruments in the U.S. Stricter regulations and a growing focus on data precision, efficiency and reproducibility are driving the transition to automation in liquid handling. The need for application-specific liquid handlers will further aid product development and encourage the entry of new market competitors.
Analysis from Frost & Sullivan, US Liquid Handling Market, estimates this market to reach $974 million in 2021 at a compound annual growth rate of 5.4 percent from 2014.
For complimentary access to more information on this research, please visit: http://bit.ly/1PSnJuU.
"Liquid handling systems are increasingly being used on the front end of growing downstream applications, such as next-generation sequencing, mass spectrometry, cell analysis and flow cytometry," said Frost & Sullivan Healthcare Senior Industry Analyst Christi Bird. "As these downstream application and assay needs change, the associated sample preparation requires change, driving new product development in liquid handling."
While the benefits of automated workflows over manual methods are compelling, some labs in the U.S. continue to view automated liquid handling as an unnecessary luxury. Additionally, persisting economic and funding challenges continue to restrain budgets and curb the sales of liquid handling systems.
However, the launch of lower priced benchtop liquid handling instruments for smaller laboratories will help competitors secure a wider customer base.
"Smaller labs are gaining access to automated liquid handling as suppliers launch benchtop instruments and simple 'pipette-in-a-box' automated tools," noted Bird. "The rise in the uptake of automated liquid handling tools will increase throughput, in turn fuelling the use of consumables and adding to revenues in the liquid handling space."
US Liquid Handling Market is part of the Life Sciences (http://www.lifesciences.frost.com) Growth Partnership Service program. Frost & Sullivan's related studies include: Western European Liquid Handling Market, Western European Immunochemistry Market and US Laboratory Information Management Systems (LIMS) Market. All studies included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
US Liquid Handling Market
Corporate Communications – North America
P: 210. 247.2450
E: [email protected]
SOURCE Frost & Sullivan